Advertisement
Pharmaceutical industry-sponsored studies are more likely to report favorable estimates in cost-effectiveness analysis of drugs used in breast cancer treatment

Industry-Led Oncology Trials May Inflate Cost-Effectiveness

0
Breast cancer cost-effectiveness analyses show favorable estimates with industry funding
Postmenopausal women with hormone receptor-positive ductal carcinoma in situ have similar recurrence rates of disease whether they take tamoxifen or the aromatase inhibitor anastrozole after surgery

SABCS: Tamoxifen, Anastrozole Both Prevent Recurrence in DCIS

0
However, side effects differ for the two medications
Laser ablation may be an effective way to treat small breast cancers

SABCS: Laser Ablation May Be an Alternative Breast Cancer Tx

0
Procedure shows promise on tumors up to 2 cm in diameter, but more study is needed
For breast and colorectal cancer survivors

Mindfulness Tx Aids Cancer-Linked Cognitive Impairment

0
Benefits for breast and colorectal cancer survivors with mindfulness-based stress reduction
Cognitive behavioral therapy and antidepressants could both be equally effective as stand-alone treatments for major depressive disorder

Cognitive Therapy, Meds Equally Effective for Major Depression

0
Researchers find both treatments can benefit patients with major depressive disorder
Too few U.S. schools teach students how to protect themselves from HIV and other sexually transmitted diseases

CDC: More STD Prevention Education Needed in Schools

0
Fewer than half of high schools, one-fifth of middle schools cover all 16 recommended topics
Women with early-stage breast cancer may survive longer if they opt for lumpectomy followed by radiation

SABCS: In Early Breast CA, Breast-Conserving Tx Beats Mastectomy

0
Study suggests 21 percent greater odds of survival after 10 years
The sooner early-stage breast cancer patients have surgery following their diagnosis

Timing May Be Key to Success for Early Breast CA Treatment

0
Scheduling the operation as soon as possible after diagnosis seems to raise odds for survival
The Dignitana DigniCap Cooling System cap has been approved by the U.S. Food and Drug Administration to help prevent hair loss in women undergoing chemotherapy for breast cancer.

FDA Approves Cooling Cap to Reduce Chemo-Linked Hair Loss

0
Designed for women diagnosed with breast cancer
More than one in four doctors-in-training may be depressed

Depression Not Uncommon Among Resident Physicians

0
Grueling medical training may help explain finding